Synapse Open Synapse
Biology

FDA starts review of Roche’s multiple sclerosis pill

BioPharma Dive · · 2 min read

The FDA previously hadn’t ever accepted an application of a drug like fenebrutinib in two major forms of MS. But safety questions still hang over Roche’s program.

Latest from BioPharma Dive